HEADER TRANSFERASE 19-SEP-18 6HP9 TITLE STRUCTURE OF THE KINASE DOMAIN OF HUMAN DDR1 IN COMPLEX WITH A 2- TITLE 2 AMINO-2,3-DIHYDRO-1H-INDENE-5-CARBOXAMIDE-BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE COMPND 5 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE COMPND 6 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE COMPND 7 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR, COMPND 8 TYROSINE-PROTEIN KINASE CAK; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS DDR1, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.M.PINKAS,A.E.FOX,K.KUPINSKA,N.A.BURGESS-BROWN,F.VON DELFT, AUTHOR 2 C.H.ARROWSMITH,A.M.EDWARDS,C.BOUNTRA,A.N.BULLOCK,STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM (SGC) REVDAT 4 24-JAN-24 6HP9 1 REMARK REVDAT 3 04-SEP-19 6HP9 1 JRNL REVDAT 2 31-JUL-19 6HP9 1 JRNL REVDAT 1 30-JAN-19 6HP9 0 JRNL AUTH D.ZHU,H.HUANG,D.M.PINKAS,J.LUO,D.GANGULY,A.E.FOX,E.ARNER, JRNL AUTH 2 Q.XIANG,Z.C.TU,A.N.BULLOCK,R.A.BREKKEN,K.DING,X.LU JRNL TITL 2-AMINO-2,3-DIHYDRO-1H-INDENE-5-CARBOXAMIDE-BASED DISCOIDIN JRNL TITL 2 DOMAIN RECEPTOR 1 (DDR1) INHIBITORS: DESIGN, SYNTHESIS, AND JRNL TITL 3 IN VIVO ANTIPANCREATIC CANCER EFFICACY. JRNL REF J.MED.CHEM. V. 62 7431 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31310125 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00365 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 49056 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT : 2361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.1111 - 5.0388 1.00 2937 158 0.1908 0.2152 REMARK 3 2 5.0388 - 3.9997 1.00 2826 159 0.1549 0.1808 REMARK 3 3 3.9997 - 3.4942 1.00 2777 132 0.1668 0.1964 REMARK 3 4 3.4942 - 3.1747 1.00 2772 146 0.1953 0.2653 REMARK 3 5 3.1747 - 2.9472 1.00 2742 162 0.2134 0.2629 REMARK 3 6 2.9472 - 2.7734 1.00 2760 130 0.2104 0.2475 REMARK 3 7 2.7734 - 2.6345 1.00 2713 147 0.2075 0.2766 REMARK 3 8 2.6345 - 2.5198 1.00 2744 124 0.2168 0.2942 REMARK 3 9 2.5198 - 2.4228 1.00 2734 149 0.2143 0.2867 REMARK 3 10 2.4228 - 2.3392 1.00 2733 124 0.2233 0.3067 REMARK 3 11 2.3392 - 2.2661 1.00 2732 115 0.2324 0.2788 REMARK 3 12 2.2661 - 2.2013 1.00 2719 126 0.2524 0.2793 REMARK 3 13 2.2013 - 2.1433 1.00 2691 138 0.2520 0.3297 REMARK 3 14 2.1433 - 2.0910 1.00 2727 139 0.2728 0.3228 REMARK 3 15 2.0910 - 2.0435 1.00 2712 151 0.3000 0.3617 REMARK 3 16 2.0435 - 2.0000 1.00 2685 119 0.3268 0.4091 REMARK 3 17 2.0000 - 1.9600 1.00 2691 142 0.3643 0.4167 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.750 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4779 REMARK 3 ANGLE : 0.835 6481 REMARK 3 CHIRALITY : 0.049 699 REMARK 3 PLANARITY : 0.006 901 REMARK 3 DIHEDRAL : 18.538 2905 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200012000. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49094 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 61.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6GWR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:2 PROTEIN TO MOTHER LIQUOR PROTEIN: REMARK 280 12 MG/ML IN 50 MM HEPES PH 7.5, 300 MM NACL, 0.5 MM TCEP, 2% REMARK 280 DMSO, 1 MM COMPOUND MOTHER LIQUOR: 25% PEG 1500, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.25500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.44000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.94500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.44000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.25500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.94500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 720 REMARK 465 LYS A 721 REMARK 465 ALA A 722 REMARK 465 ALA A 723 REMARK 465 GLU A 724 REMARK 465 GLY A 725 REMARK 465 ALA A 726 REMARK 465 PRO A 727 REMARK 465 GLY A 728 REMARK 465 ASP A 729 REMARK 465 GLY A 730 REMARK 465 GLN A 731 REMARK 465 ALA A 732 REMARK 465 ALA A 733 REMARK 465 LEU A 910 REMARK 465 ASN A 911 REMARK 465 THR A 912 REMARK 465 VAL A 913 REMARK 465 SER B 599 REMARK 465 MET B 600 REMARK 465 PRO B 601 REMARK 465 ARG B 602 REMARK 465 VAL B 636 REMARK 465 SER B 637 REMARK 465 LEU B 638 REMARK 465 ASP B 639 REMARK 465 PHE B 640 REMARK 465 PRO B 641 REMARK 465 LEU B 642 REMARK 465 ASN B 643 REMARK 465 VAL B 644 REMARK 465 ARG B 645 REMARK 465 LYS B 646 REMARK 465 GLY B 647 REMARK 465 LYS B 721 REMARK 465 ALA B 722 REMARK 465 ALA B 723 REMARK 465 GLU B 724 REMARK 465 GLY B 725 REMARK 465 ALA B 726 REMARK 465 PRO B 727 REMARK 465 GLY B 728 REMARK 465 ASP B 729 REMARK 465 GLY B 730 REMARK 465 GLN B 731 REMARK 465 ALA B 732 REMARK 465 ALA B 733 REMARK 465 GLN B 734 REMARK 465 LEU B 910 REMARK 465 ASN B 911 REMARK 465 THR B 912 REMARK 465 VAL B 913 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 621 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 645 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 646 CG CD CE NZ REMARK 470 ARG A 658 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 719 CG CD OE1 OE2 REMARK 470 GLN A 734 CG CD OE1 NE2 REMARK 470 ARG A 802 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 851 CG CD OE1 OE2 REMARK 470 GLN B 633 CG CD OE1 NE2 REMARK 470 HIS B 648 CG ND1 CD2 CE1 NE2 REMARK 470 ASP B 694 CG OD1 OD2 REMARK 470 GLU B 776 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 614 135.14 -177.16 REMARK 500 ASN A 643 66.32 -118.97 REMARK 500 ARG A 765 -3.58 77.73 REMARK 500 ASP A 766 43.42 -151.07 REMARK 500 SER A 788 21.56 -140.28 REMARK 500 ARG A 802 -102.42 -116.57 REMARK 500 GLU A 907 -71.09 -140.05 REMARK 500 ARG B 765 -7.83 76.05 REMARK 500 ASP B 766 44.53 -146.76 REMARK 500 ASP B 784 101.28 -161.75 REMARK 500 GLU B 907 -55.46 -134.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GKB A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GKB B 1001 DBREF 6HP9 A 601 913 UNP Q08345 DDR1_HUMAN 601 913 DBREF 6HP9 B 601 913 UNP Q08345 DDR1_HUMAN 601 913 SEQADV 6HP9 SER A 599 UNP Q08345 EXPRESSION TAG SEQADV 6HP9 MET A 600 UNP Q08345 EXPRESSION TAG SEQADV 6HP9 SER B 599 UNP Q08345 EXPRESSION TAG SEQADV 6HP9 MET B 600 UNP Q08345 EXPRESSION TAG SEQRES 1 A 315 SER MET PRO ARG VAL ASP PHE PRO ARG SER ARG LEU ARG SEQRES 2 A 315 PHE LYS GLU LYS LEU GLY GLU GLY GLN PHE GLY GLU VAL SEQRES 3 A 315 HIS LEU CYS GLU VAL ASP SER PRO GLN ASP LEU VAL SER SEQRES 4 A 315 LEU ASP PHE PRO LEU ASN VAL ARG LYS GLY HIS PRO LEU SEQRES 5 A 315 LEU VAL ALA VAL LYS ILE LEU ARG PRO ASP ALA THR LYS SEQRES 6 A 315 ASN ALA ARG ASN ASP PHE LEU LYS GLU VAL LYS ILE MET SEQRES 7 A 315 SER ARG LEU LYS ASP PRO ASN ILE ILE ARG LEU LEU GLY SEQRES 8 A 315 VAL CYS VAL GLN ASP ASP PRO LEU CYS MET ILE THR ASP SEQRES 9 A 315 TYR MET GLU ASN GLY ASP LEU ASN GLN PHE LEU SER ALA SEQRES 10 A 315 HIS GLN LEU GLU ASP LYS ALA ALA GLU GLY ALA PRO GLY SEQRES 11 A 315 ASP GLY GLN ALA ALA GLN GLY PRO THR ILE SER TYR PRO SEQRES 12 A 315 MET LEU LEU HIS VAL ALA ALA GLN ILE ALA SER GLY MET SEQRES 13 A 315 ARG TYR LEU ALA THR LEU ASN PHE VAL HIS ARG ASP LEU SEQRES 14 A 315 ALA THR ARG ASN CYS LEU VAL GLY GLU ASN PHE THR ILE SEQRES 15 A 315 LYS ILE ALA ASP PHE GLY MET SER ARG ASN LEU TYR ALA SEQRES 16 A 315 GLY ASP TYR TYR ARG VAL GLN GLY ARG ALA VAL LEU PRO SEQRES 17 A 315 ILE ARG TRP MET ALA TRP GLU CYS ILE LEU MET GLY LYS SEQRES 18 A 315 PHE THR THR ALA SER ASP VAL TRP ALA PHE GLY VAL THR SEQRES 19 A 315 LEU TRP GLU VAL LEU MET LEU CYS ARG ALA GLN PRO PHE SEQRES 20 A 315 GLY GLN LEU THR ASP GLU GLN VAL ILE GLU ASN ALA GLY SEQRES 21 A 315 GLU PHE PHE ARG ASP GLN GLY ARG GLN VAL TYR LEU SER SEQRES 22 A 315 ARG PRO PRO ALA CYS PRO GLN GLY LEU TYR GLU LEU MET SEQRES 23 A 315 LEU ARG CYS TRP SER ARG GLU SER GLU GLN ARG PRO PRO SEQRES 24 A 315 PHE SER GLN LEU HIS ARG PHE LEU ALA GLU ASP ALA LEU SEQRES 25 A 315 ASN THR VAL SEQRES 1 B 315 SER MET PRO ARG VAL ASP PHE PRO ARG SER ARG LEU ARG SEQRES 2 B 315 PHE LYS GLU LYS LEU GLY GLU GLY GLN PHE GLY GLU VAL SEQRES 3 B 315 HIS LEU CYS GLU VAL ASP SER PRO GLN ASP LEU VAL SER SEQRES 4 B 315 LEU ASP PHE PRO LEU ASN VAL ARG LYS GLY HIS PRO LEU SEQRES 5 B 315 LEU VAL ALA VAL LYS ILE LEU ARG PRO ASP ALA THR LYS SEQRES 6 B 315 ASN ALA ARG ASN ASP PHE LEU LYS GLU VAL LYS ILE MET SEQRES 7 B 315 SER ARG LEU LYS ASP PRO ASN ILE ILE ARG LEU LEU GLY SEQRES 8 B 315 VAL CYS VAL GLN ASP ASP PRO LEU CYS MET ILE THR ASP SEQRES 9 B 315 TYR MET GLU ASN GLY ASP LEU ASN GLN PHE LEU SER ALA SEQRES 10 B 315 HIS GLN LEU GLU ASP LYS ALA ALA GLU GLY ALA PRO GLY SEQRES 11 B 315 ASP GLY GLN ALA ALA GLN GLY PRO THR ILE SER TYR PRO SEQRES 12 B 315 MET LEU LEU HIS VAL ALA ALA GLN ILE ALA SER GLY MET SEQRES 13 B 315 ARG TYR LEU ALA THR LEU ASN PHE VAL HIS ARG ASP LEU SEQRES 14 B 315 ALA THR ARG ASN CYS LEU VAL GLY GLU ASN PHE THR ILE SEQRES 15 B 315 LYS ILE ALA ASP PHE GLY MET SER ARG ASN LEU TYR ALA SEQRES 16 B 315 GLY ASP TYR TYR ARG VAL GLN GLY ARG ALA VAL LEU PRO SEQRES 17 B 315 ILE ARG TRP MET ALA TRP GLU CYS ILE LEU MET GLY LYS SEQRES 18 B 315 PHE THR THR ALA SER ASP VAL TRP ALA PHE GLY VAL THR SEQRES 19 B 315 LEU TRP GLU VAL LEU MET LEU CYS ARG ALA GLN PRO PHE SEQRES 20 B 315 GLY GLN LEU THR ASP GLU GLN VAL ILE GLU ASN ALA GLY SEQRES 21 B 315 GLU PHE PHE ARG ASP GLN GLY ARG GLN VAL TYR LEU SER SEQRES 22 B 315 ARG PRO PRO ALA CYS PRO GLN GLY LEU TYR GLU LEU MET SEQRES 23 B 315 LEU ARG CYS TRP SER ARG GLU SER GLU GLN ARG PRO PRO SEQRES 24 B 315 PHE SER GLN LEU HIS ARG PHE LEU ALA GLU ASP ALA LEU SEQRES 25 B 315 ASN THR VAL HET GKB A1001 35 HET GKB B1001 35 HETNAM GKB (2~{R})-~{N}-[3-(4-METHYLIMIDAZOL-1-YL)-5- HETNAM 2 GKB (TRIFLUOROMETHYL)PHENYL]-2-(PYRIMIDIN-5-YLAMINO)-2,3- HETNAM 3 GKB DIHYDRO-1~{H}-INDENE-5-CARBOXAMIDE FORMUL 3 GKB 2(C25 H21 F3 N6 O) FORMUL 5 HOH *374(H2 O) HELIX 1 AA1 PRO A 606 LEU A 610 5 5 HELIX 2 AA2 SER A 631 LEU A 635 5 5 HELIX 3 AA3 THR A 662 SER A 677 1 16 HELIX 4 AA4 ASP A 708 ALA A 715 1 8 HELIX 5 AA5 SER A 739 LEU A 760 1 22 HELIX 6 AA6 ALA A 768 ARG A 770 5 3 HELIX 7 AA7 GLU A 776 PHE A 778 5 3 HELIX 8 AA8 ARG A 789 TYR A 796 5 8 HELIX 9 AA9 PRO A 806 MET A 810 5 5 HELIX 10 AB1 ALA A 811 GLY A 818 1 8 HELIX 11 AB2 THR A 821 MET A 838 1 18 HELIX 12 AB3 THR A 849 ASP A 863 1 15 HELIX 13 AB4 PRO A 877 TRP A 888 1 12 HELIX 14 AB5 GLU A 891 ARG A 895 5 5 HELIX 15 AB6 PRO A 897 GLU A 907 1 11 HELIX 16 AB7 PRO B 606 LEU B 610 5 5 HELIX 17 AB8 SER B 631 LEU B 635 5 5 HELIX 18 AB9 THR B 662 SER B 677 1 16 HELIX 19 AC1 ASP B 708 ALA B 715 1 8 HELIX 20 AC2 SER B 739 LEU B 760 1 22 HELIX 21 AC3 ALA B 768 ARG B 770 5 3 HELIX 22 AC4 GLU B 776 PHE B 778 5 3 HELIX 23 AC5 ARG B 789 TYR B 796 5 8 HELIX 24 AC6 PRO B 806 MET B 810 5 5 HELIX 25 AC7 ALA B 811 GLY B 818 1 8 HELIX 26 AC8 THR B 821 MET B 838 1 18 HELIX 27 AC9 THR B 849 ASP B 863 1 15 HELIX 28 AD1 PRO B 877 TRP B 888 1 12 HELIX 29 AD2 GLU B 891 ARG B 895 5 5 HELIX 30 AD3 PRO B 897 GLU B 907 1 11 SHEET 1 AA1 5 ARG A 611 GLU A 618 0 SHEET 2 AA1 5 GLY A 622 VAL A 629 -1 O VAL A 624 N LEU A 616 SHEET 3 AA1 5 LEU A 650 LEU A 657 -1 O ILE A 656 N GLU A 623 SHEET 4 AA1 5 CYS A 698 ASP A 702 -1 O THR A 701 N ALA A 653 SHEET 5 AA1 5 LEU A 687 CYS A 691 -1 N GLY A 689 O ILE A 700 SHEET 1 AA2 2 GLN A 717 LEU A 718 0 SHEET 2 AA2 2 THR A 737 ILE A 738 1 O ILE A 738 N GLN A 717 SHEET 1 AA3 2 CYS A 772 VAL A 774 0 SHEET 2 AA3 2 ILE A 780 ILE A 782 -1 O LYS A 781 N LEU A 773 SHEET 1 AA4 2 TYR A 797 ARG A 798 0 SHEET 2 AA4 2 VAL A 804 LEU A 805 -1 O LEU A 805 N TYR A 797 SHEET 1 AA5 5 ARG B 611 GLU B 618 0 SHEET 2 AA5 5 GLY B 622 VAL B 629 -1 O LEU B 626 N GLU B 614 SHEET 3 AA5 5 LEU B 650 LEU B 657 -1 O ILE B 656 N GLU B 623 SHEET 4 AA5 5 CYS B 698 ASP B 702 -1 O THR B 701 N ALA B 653 SHEET 5 AA5 5 LEU B 687 CYS B 691 -1 N LEU B 688 O ILE B 700 SHEET 1 AA6 2 GLN B 717 LEU B 718 0 SHEET 2 AA6 2 THR B 737 ILE B 738 1 O ILE B 738 N GLN B 717 SHEET 1 AA7 2 CYS B 772 VAL B 774 0 SHEET 2 AA7 2 ILE B 780 ILE B 782 -1 O LYS B 781 N LEU B 773 CISPEP 1 ASP A 695 PRO A 696 0 -2.62 CISPEP 2 ASP B 695 PRO B 696 0 5.72 SITE 1 AC1 17 ALA A 653 GLU A 672 ILE A 675 MET A 676 SITE 2 AC1 17 LEU A 679 ILE A 684 ILE A 685 THR A 701 SITE 3 AC1 17 ASP A 702 TYR A 703 MET A 704 PHE A 762 SITE 4 AC1 17 HIS A 764 ALA A 783 ASP A 784 HOH A1101 SITE 5 AC1 17 HOH A1175 SITE 1 AC2 17 ALA B 653 GLU B 672 ILE B 675 MET B 676 SITE 2 AC2 17 LEU B 679 ILE B 684 ILE B 685 THR B 701 SITE 3 AC2 17 ASP B 702 TYR B 703 MET B 704 PHE B 762 SITE 4 AC2 17 HIS B 764 ALA B 783 ASP B 784 GLN B 847 SITE 5 AC2 17 HOH B1129 CRYST1 62.510 65.890 162.880 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015997 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015177 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006139 0.00000